Franco Rutili

Franco Rutili

Inversor de Capital Privado en Innogest SGR SpA .

Health Technology
Commercial Services
Consumer Services

Perfil

Franco Rutili is currently a Healthcare Venture Partner at Innogest SGR SpA.
He previously served as Chairman of the Board of Directors at Atricath SpA from 2013 to 2015, Director at NanoCellect Biomedical, Inc. from 2021 to 2022, Vice President-Development at Shaman Pharmaceuticals, Inc. from 1991 to 1995, Board Member at EryDel SpA and Menarini-Silicon Biosystems SpA from 2010 to 2013, Board Member at Betaglue Technologies SpA from 2016 to 2020, and Board Observer at Renovacor, Inc. from 2019 to 2021.
He also served as Principal at Pharmacia & Upjohn SpA from 1996 to 2003 and at Pfizer Srl (Italy) from 2003 to 2008.
Mr. Rutili has an undergraduate degree from the University of Uppsala and a graduate degree from the University of Southern Brittany.

Cargos activos de Franco Rutili

EmpresasCargoInicio
Inversor de Capital Privado 01/01/2011
Todos los cargos activos de Franco Rutili

Antiguos cargos conocidos de Franco Rutili.

EmpresasCargoFin
Director/Miembro de la Junta 01/07/2022
RENOVACOR, INC. Director/Miembro de la Junta 01/09/2021
Director/Miembro de la Junta 01/09/2020
Director/Miembro de la Junta 01/01/2015
Director/Miembro de la Junta 01/08/2013
Ver el detalle de la experiencia de Franco Rutili.

Formación de Franco Rutili.

University of Uppsala Undergraduate Degree
University of Southern Brittany Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Franco Rutili.

Relaciones

45

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas11

Health Technology

Finance

Health Technology

Electronic Technology

Commercial Services

Pharmacia & Upjohn SpA

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Ver las conexiones de la empresa
-40% Prolongación excepcional: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA